« Back
Home /
RAT ANTI MOUSE CD25

RAT ANTI MOUSE CD25

Manufacturer	GENWAY
Category	Oncology Antibodies By Cell Type Hematology Leukemia Lymphoma Immunoprecipitation Primary Antibodies
Type	Antibody
Specific against	Mouse
Applications	IP
Amount	0.1 mg
Host	Rat
Item no.	20-783-314559
eClass 6.1	32160702
eClass 9.0	32160702
Available
Genway ID:	GWB-27E79F
Specificity:	CD25
Isotype:	IgG1
Preparation:	Purified IgG prepared by affinity chromatography on Protein G from tissue culture supernatant
Preservative Stabilisers:		0. 09% Sodium Azide (NaN3)Approx. Protein Concentrations: IgG concentration 1. 0mg/ml
Immunogen:	B6. 1 CTL cell line
Specificity:	Reacts with the low affinity alpha chain of the interleukin-2 receptor present on activated T and B cells in mice. Clone PC61. 5. 3 is reported to inhibit IL-2 binding and IL-2 dependent proliferation. AbD Recommended Negative Controls: RAT IgG1 NEGATIVE CONTROLRecommended Secondary Antibodies: Goat Anti Rat IgGRabbit Anti Rat IgGGoat Anti Rat IgG (MOUSE ADSORBED)
Function:	Receptor for interleukin-2. Subunit structureNon-covalent dimer of an alpha and a beta subunit. IL2R exists in 3 different forms: a high affinity dimer an intermediate affinity monomer (beta subunit) and a low affinity monomer (alpha subunit). The high and intermediate affinity forms also associate with a gamma subunit. Subcellular locationMembrane; Single-pass type I membrane protein. Sequence similaritiesContains 2 Sushi (CCP/SCR) domains.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 mg

available

Delivery expected until 5/9/2024